Reinforcement-enhancing effects of NRT
NRT 的强化作用
基本信息
- 批准号:9084517
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-15 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAddressAnimal ModelAreaAttenuatedAuditoryBupropionCigaretteClinicalCuesDependenceDrug KineticsEarly treatmentEnvironmentFutureHumanIntakeKineticsMusicNegative ReinforcementsNeurobiologyNicotineNicotine DependenceNoiseNoseOutcomePharmaceutical PreparationsPlacebosPredictive ValuePsychological reinforcementRelapseReplacement TherapyResearchRewardsRodentSelf-AdministeredSensorySmokerSmokingSpecificityStimulusTestingTherapeuticTimeTobacco smokingVisualWithdrawalcigarette smokingclinical applicationclinical predictorsclinically relevantdesigndrug of abusenicotine replacementpre-clinicalpre-clinical researchpredictive of treatment responsepreventpublic health relevancereinforcersecondary analysissmoking cessationsuccessvarenicline
项目摘要
DESCRIPTION (provided by applicant): "Reinforcement enhancing effects of NRT" Nicotine clearly has primary and secondary reinforcing effects, as nicotine is self-administered and stimuli associated with nicotine ("cues") can become conditioned reinforcers of responding. Overlooked until recently is non-human research showing that nicotine has a third reinforcing function, that of reinforcement enhancing effects, or increasing reinforcing efficacy of rewards unrelated to nicotine intake. Notably, we recently demonstrated reinforcement enhancing effects, perhaps for the first time in humans, of nicotine intake via tobacco smoking, supporting clinical applicability of these preclinical research findings. Similar effects in both nondependent
and dependent smokers and other findings indicated dependence and withdrawal as not necessary for these nicotine effects to occur. Yet, these effects may be specific to only some types of reinforcers, especially positive sensory rewards (visual, auditory, etc.). Also, nicotine' kinetics do not influence its reinforcement enhancing effects in animal models, in contrast to its primary and secondary effects, but reinforcement enhancing effects of rapid versus gradual intake of nicotine per se warrants confirmation in humans. Nicotine via means other than smoking, such as nicotine replacement therapy (NRT), can assess effects of nicotine per se on enhancing reinforcement and determine its clinical predictive value in quitting smokers. NRT also can test if pharmacokinetics influences this reinforcement enhancing effect, via rapid (nasal spray) vs. gradual (patch) nicotine intake. Study 1 will examine influences of nicotine per se (versus placebo) on responding for reinforcers in 60 nondependent and dependent smokers to confirm our results with nicotine via smoking, using our well-validated within-subjects design to increase power. We hypothesize that responding will be greater after NRT (patch or spray) versus placebo, indicating reinforcement enhancing effects of nicotine per se, and we will explore whether these effects differ by type of reward, showing specificity. Study 2 will determine if greater reinforced responding due to NRT early in abstinence predicts days to relapse with NRT in 60 treatment-seeking smokers making a permanent quit attempt. We hypothesize that a greater increase in reinforced responding due to NRT early in cessation will predict longer duration of abstinence. This research is highly significant because demonstrating reinforcement enhancing effects of nicotine per se in humans would have important implications for understanding: an overlooked reinforcing effect of nicotine that may help account for persistence of dependence, some of the efficacy of NRT for aiding smoking cessation, and perhaps potentially similar actions of other therapeutic medications or other drugs of abuse.
描述(由申请人提供):“NRT的强化增强作用”尼古丁显然具有初级和次级强化作用,因为尼古丁是自我给药的,与尼古丁相关的刺激(“线索”)可以成为反应的条件反射。直到最近才被忽视的是,非人类研究表明尼古丁具有第三种强化功能,即强化增强效应,或增加与尼古丁摄入无关的奖励的强化功效。值得注意的是,我们最近证明了通过吸烟摄入尼古丁的强化增强作用,这可能是人类首次,支持这些临床前研究结果的临床适用性。在两种非依赖性
和依赖性吸烟者,其他研究结果表明,依赖和戒断并不是这些尼古丁效应发生的必要条件。然而,这些效应可能只针对某些类型的奖励,特别是积极的感官奖励(视觉,听觉等)。此外,尼古丁的动力学不影响其在动物模型中的强化增强作用,与其主要和次要作用相反,但快速与逐渐摄入尼古丁本身的强化增强作用需要在人类中得到证实。尼古丁通过吸烟以外的方式,如尼古丁替代疗法(NRT),可以评估尼古丁本身对增强强化的影响,并确定其在戒烟中的临床预测价值。NRT还可以测试药代动力学是否影响这种强化增强效应,通过快速(鼻喷雾)与渐进(贴片)尼古丁摄入。研究1将检查尼古丁本身(与安慰剂相比)对60名非依赖性和依赖性吸烟者对尼古丁应答的影响,以确认我们通过吸烟获得的尼古丁结果,使用我们经过充分验证的受试者内设计来增加功效。我们假设,与安慰剂相比,NRT(贴剂或喷雾剂)后的反应会更大,表明尼古丁本身的强化增强作用,我们将探讨这些作用是否因奖励类型而异,显示特异性。研究2将确定在60名寻求永久戒烟尝试的吸烟者中,戒烟早期NRT引起的更大强化反应是否预测NRT复发的天数。我们假设,在戒烟早期,NRT引起的强化反应的增加更大,这将预示着更长的戒烟时间。这项研究非常重要,因为证明尼古丁本身在人类中的强化增强作用将对理解以下方面具有重要意义:尼古丁被忽视的强化作用可能有助于解释依赖的持续性,NRT帮助戒烟的一些功效,以及其他治疗药物或其他滥用药物的潜在类似作用。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differences in acute reinforcement across reduced nicotine content cigarettes.
尼古丁含量降低的香烟的急性强化差异。
- DOI:10.1007/s00213-020-05509-9
- 发表时间:2020
- 期刊:
- 影响因子:3.4
- 作者:Perkins,KennethA;Karelitz,JoshuaL
- 通讯作者:Karelitz,JoshuaL
Preclinical and clinical research on the discriminative stimulus effects of nicotine.
尼古丁辨别刺激作用的临床前和临床研究。
- DOI:10.1016/j.neuropharm.2020.108063
- 发表时间:2020
- 期刊:
- 影响因子:4.7
- 作者:Shoaib,Mohammed;Perkins,KennethA
- 通讯作者:Perkins,KennethA
Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray.
通过贴片和鼻喷雾剂增强尼古丁的效果。
- DOI:10.1093/ntr/nty038
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Perkins,KennethA;Karelitz,JoshuaL;Boldry,MargaretC
- 通讯作者:Boldry,MargaretC
Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans.
- DOI:10.3389/fpsyt.2017.00065
- 发表时间:2017
- 期刊:
- 影响因子:4.7
- 作者:Perkins KA;Karelitz JL;Boldry MC
- 通讯作者:Boldry MC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH Alan PERKINS其他文献
KENNETH Alan PERKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH Alan PERKINS', 18)}}的其他基金
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10452567 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10620310 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10328576 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Threshold Dose for Nicotine Discrimination in Cigarettes
香烟中尼古丁歧视的阈剂量
- 批准号:
8573038 - 财政年份:2013
- 资助金额:
$ 23.1万 - 项目类别:
Threshold Dose for Nicotine Discrimination in Cigarettes
香烟中尼古丁歧视的阈剂量
- 批准号:
8720746 - 财政年份:2013
- 资助金额:
$ 23.1万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Operating Grants














{{item.name}}会员




